Search
moon
sun

T59. Aortic Dissection

A. Introduction and epidemiology

โ€ข
Acute aortic syndrome
โ—ฆ
Aortic dissection
โ—ฆ
Penetrating atherosclerotic ulcer
โ—ฆ
Intramural hematoma (IMH)
โ—ฆ
Aortic aneurysmal leakage
โ—ฆ
ruptured abdominal aortic aneurysm
โ€ข
Incidence : ์—ฐ๊ฐ„ 2.9~4.7 cases / 100,000 ๋ช…
โ€ข
์ˆ˜์ˆ ํ™˜์ž์—์„œ mortality rate : 1 year 92%, 5 year 77%, 10 year 57%
โ€ข
22%์˜ ํ™˜์ž๋Š” ์ง„๋‹จ ์ „์— ์‚ฌ๋ง
โ€ข
Marfan syn.์˜ M/C cardiovascular complication : aortic root disease์™€ type A dissection

B. Pathophysiology

โ€ข
Acute aortic syn.์€ chronic hypertension๊ณผ media of aortic wall์˜ degeneration ์„ ์ผ์œผํ‚ฌ ์ˆ˜ ์žˆ๋Š” ์š”์ธ๋“ค๋กœ ์ธํ•ด ๋ฐœ์ƒํ•œ๋‹ค.
โ€ข
Risk factor : Medial layer๋ฅผ ์•ฝํ•˜๊ฒŒ ํ•˜๊ณ  , intimal wall stress ๋ฅผ ์ฆ๊ฐ€์‹œํ‚ค๋Š” ์š”์†Œ
โ—ฆ
Bicuspid aortic valve
โ—ฆ
Marfan syn.
โ—ฆ
Ehlers-Danlos syn
โ—ฆ
Aortic dissection์˜ ๊ฐ€์กฑ๋ ฅ
โ—ฆ
๋งŒ์„ฑ ์ฝ”์นด์ธ ๋˜๋Š” ์•”ํŽ˜ํƒ€๋ฏผ ์‚ฌ์šฉ, ์‹ฌ์žฅ ์ˆ˜์ˆ  ๊ณผ๊ฑฐ๋ ฅ
โ€ข
์„ฑ๋ณ„์— ๋”ฐ๋ฅธ ์ฐจ์ด๊ฐ€ ์žˆ๋‹ค
โ—ฆ
Intramural hematoma๋Š” ์—ฌ์„ฑ์—์„œ ๋” ํ”ํ•˜๋‹ค (62%)
โ—ฆ
์—ฌ์„ฑ์—์„œ aortic dissection์€ inpatient complication์ด ํ”ํ•˜๋ฉฐ inhospital mortality ๊ฐ€ ๋†’๋‹ค

B1. Aortic dissection

โ€ข
Intima์˜ ์†์ƒ์œผ๋กœ ํ˜ˆ๋ฅ˜๊ฐ€ media๋กœ ๋“ค์–ด์™€ intima์™€ adventitial layer ์‚ฌ์ด๊ฐ€ ๋ฐ•๋ฆฌ๋จ

(1) Most common intimal tear site

โ€ข
50~65% : Sinotubular junction at the start of the acending aorta
โ€ข
20~30%: Just beyond the left subclavian artery at the junction between the acending and descending aorta

(2) Bimodal age distribution

โ€ข
์œ„ํ—˜์ธ์ž๊ฐ€ ์žˆ๋Š” ์ Š์€ ํ™˜์ž
โ€ข
>50 ์„ธ์˜ ๋งŒ์„ฑ ๊ณ ํ˜ˆ์••, ํ—ˆํ˜ˆ์„ฑ ์‹ฌ์žฅ ์งˆํ™˜์ด ์žˆ๋Š” ํ™˜์ž

(3) Classification

โ€ข
Stanford type A dissection : ascending aorta๋ฅผ ํฌํ•จํ•œ ๋ชจ๋“  ๊ฒฝ์šฐ type B dissection : descending aorta ๋งŒ ์นจ๋ฒ”
โ€ข
Debakey type 1 dissection : ascending aorta, arch, descending aorta๋ฅผ ๋™์‹œ์— ์นจ๋ฒ” type 2 dissection : ascending aorta๋งŒ ์นจ๋ฒ” type 3 dissection : descending aorta๋งŒ ์นจ๋ฒ”

B2. Aortic intramural hematoma

โ€ข
๋ณดํ†ต vasa vasorum์˜ ์†์ƒ์œผ๋กœ ์ƒ๊ธฐ๋Š” aortic media infarction ์˜ ๊ฒฐ๊ณผ๋กœ ์ƒ๊น€
โ€ข
Penetrating atherosclerotic ulcer์—์„œ ์ง„ํ–‰๋  ์ˆ˜ ์žˆ๊ณ  ์Šค์Šค๋กœ ํก์ˆ˜๋˜๊ธฐ๋„ ํ•˜๊ณ  dissection ์œผ๋กœ ์ง„ํ–‰ํ•  ์ˆ˜ ์žˆ๋‹ค

C. Clinical features

C1. History

โ€ข
์ „ํ˜•์ ์œผ๋กœ ๊ฐ‘์ž‘์Šค๋Ÿฝ๊ณ  ๊ทน์‹ฌํ•œ ํ‰ํ†ต, scapula ์‚ฌ์ด๋กœ ๋ฐฉ์‚ฌ, ์ฃฝ์„ ๊ฒƒ ๊ฐ™์€ ๋А๋‚Œ
โ€ข
Sharp pain (64%), tearing or ripping pain (50%), syncope (10%)
โ€ข
Chest pain ์—†์ด ๋ฐœ์ƒํ•˜๋Š” ๊ฒฝ์šฐ๋„ ์žˆ๋‹ค (Asia report ์—์„œ๋Š” 40%๊ฐ€๋Ÿ‰)
โ€ข
Distal dissection์˜ ๊ฒฝ์šฐ ๋“ฑ, ์˜†๊ตฌ๋ฆฌ, ๋ณตํ†ต ๋“ฑ์ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ
โ€ข
Carotid a. stroke ๋ฅผ ์นจ๋ฒ”ํ•œ ๊ฒฝ์šฐ, ์ „ํ˜•์ ์ธ ์˜ ์ฆ์ƒ์„ ๋ณด์ด๋ฉฐ spinal cord blood supply ์˜ ๊ฐ€ ์ €ํ•ด๋  ๊ฒฝ์šฐ paraplegia ๋ฐœ์ƒ
โ€ข
Aortic root๊นŒ์ง€ ๋™๋ฐ˜๋œ proximal dissection์€ cardiac tamponade ๋ฐœ์ƒ ๊ฐ€๋Šฅ

C2. Physical examination

โ€ข
๋Œ€๋ถ€๋ถ„์€ ์ƒ๋Œ€์ ์œผ๋กœ ์ •์ƒ
โ€ข
Aortic insufficiency murmur : 32%
โ€ข
Radial a. or femoral a. ๋งฅ๋ฐ•์ด ์ด‰์ง€๋˜์ง€ ์•Š์Œ : 15%
โ€ข
Hypertension : 49% / Hypotension : 18~25%
โ€ข
Aneurysmal dilation์œผ๋กœ ๊ตฌ์กฐ๋ฌผ ์••๋ฐ•
โ—ฆ
Esophagus, recurrent laryngeal nerve, superior cervical sympathetic ganglion ๋“ฑ ์••๋ฐ•
โ—ฆ
Dysphagia, hoarseness, Horner synd. . ๋“ฑ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค
โ€ข
์ตœ๊ทผ ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด aortic dissection์˜ 3๊ฐ€์ง€ ์ž„์ƒ ๋ฒ”์ฃผ์— ๋”ฐ๋ผ 12 ์š”์†Œ๋ฅผ ๋ถ„์„ํ–ˆ๊ณ  ์ ์ˆ˜๋ฅผ ๋งค๊ฒจ ๊ทธ ์ ์ˆ˜๊ฐ€ ์ฆ์ƒ์ด ์žˆ๋Š” acute aortic dissection ํ™˜์ž์™€ ์œ ์˜ํ•œ ๊ด€๊ณ„๊ฐ€ ์žˆ์Œ์„ ํ™•์ธํ•จ. (the Aortic Dissetion Detection Risk Score ; ๊ฐ category๋ณ„ 1์  , 0~3 ์  ๋ฒ”์œ„)

D. Diagnosis

D1. ECG

โ€ข
ACS์™€ ๊ฐ๋ณ„ ์–ด๋ ค์›€ (Dissection coronary a. blood flow ์ œํ•œ ํ•  ์ˆ˜ ์žˆ์Œ)
โ€ข
19~31%์—์„œ๋งŒ ์ •์ƒ ECG (New Q waves, STE 3~4%, STD 15~22%, nonspecific ST, T wave change 41~62%)

D2. Biomarkers

โ€ข
D-dimer์˜ ์ง„๋‹จ์  ๊ฐ€์น˜๊ฐ€ ์—ฐ๊ตฌ๋˜์—ˆ์ง€๋งŒ debate ๊ฐ€ ์žˆ์Œ
โ€ข
์ตœ๊ทผ ์—ฐ๊ตฌ์—์„œ ์ž„์ƒ์ ์œผ๋กœ ์˜์‹ฌ๋˜๋‚˜ the Aortic Dissection Detection Risk Score ์˜ feature ์ค‘ ํ•ฉ๋‹นํ•œ ๊ฒƒ์ด ํ•˜๋‚˜ ์ดํ•˜์ด๋ฉด์„œ negative d-dimer(<500ng/ml)์ธ ๊ฒฝ์šฐ , aortic dissection ์ธ ๊ฒฝ์šฐ ์˜ ๋น„์œจ์€ ๋งค์šฐ ๋‚ฎ์•˜๋‹ค. (0.3%)
โ€ข
D-dimer โ‰ฅ 0.5 ฮผg/mL ๋ฐ ์—ฐ๋ น ์กฐ์ • D-dimer โ‰ฅ [์—ฐ๋ น(๋…„) ร— 0.01] ฮผg/mL(์ตœ์†Œ 0.5 ฮผg/mL)์„ ์–‘์„ฑ์œผ๋กœ ๋งŽ์ด ๋ณธ๋‹ค. ์ธก์ • ์‹œ๊ฐ„์— ๋”ฐ๋ผ d-dimer ๊ฐ€ ์ฐจ์ด๋‚˜์ง€๋Š” ์•Š์œผ๋ฉฐ, ์งˆํ™˜์˜ ์‹ฌ๊ฐ๋„๊ฐ€ ๊ฒฝ์ฆ์ด๋ฉด ๋‚ฎ๊ฒŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒƒ ๊ฐ™๋‹ค. (์ฐธ๊ณ ๋ฌธํ—Œ)

D3. Imaging

(1) Chest x-ray

โ€ข
์ค‘์š”ํ•œ ๋‹จ์„œ ์ œ๊ณต, ํ•˜์ง€๋งŒ 12~37% ์—์„œ ์ •์ƒ์†Œ๊ฒฌ์ด๋ฏ€๋กœ ๋ฐฐ์ œ ๋ชฉ์ ์œผ๋กœ๋Š” ์‚ฌ์šฉ ๋ถˆ๊ฐ€
โ€ข
Widened mediastinum, abnormal aortic contour, pleural effusion, displacement of aortic intimal calcification
โ€ข
Deviation of the trachea, mainstream bronchi, or esophagus

(2) CT

โ€ข
Modality of choice for diagnosis
โ€ข
์ž์„ธํ•œ ๊ตฌ์กฐ ๋ฐ ์ด์ƒ์†Œ๊ฒฌ ํ™•์ธ ๊ฐ€๋Šฅ (๋ฒ”์œ„ , end-organ damage, intramural hematoma, ) โ€ฆ
โ€ข
Coronary CT angiography (โ€œTriple rule-out" study) : Coranary a. disease, pulmonary embolism, acute aortic dissection ์„ ์ง„๋‹จํ•  ์ˆ˜ ์žˆ๋‹ค : ์ง„๋‹จ์  ๊ฐ€์น˜, ์˜ˆํ›„, ์˜๋ฃŒ์ž์› ๋“ฑ์—์„œ ๋” ์œ ๋ฆฌํ•œ ๊ฒƒ์œผ๋กœ ํ™•์ธ๋˜์ง€ ์•Š์•„ ์ถ”์ฒœ๋˜์ง€๋Š” ์•Š๋Š”๋‹ค.

(3) Other

โ€ข
์ˆ™๋ จ์ž๊ฐ€ ์‹œํ–‰ํ•˜๋Š” TEE๋Š” CT๋งŒํผ sensitive & specific ํ•˜๋‹ค
โ€ข
MRI๋Š” stable patient ์—์„œ ์‚ฌ์šฉ

E. Treatment

E1. Antihypertensives

(1) Negative inotropics (Lower BP without increasing the shear force)

(2) ฮฒ-blocker ๋ฅผ ๋ถ€์ ์‘์ฆ์ด ์—†๋Š” ํ•œ ์ดˆ๊ธฐ์— ํˆฌ์—ฌ (COR-1, LOE-B)

โ€ข
Short acting์ด ์„ ํ˜ธ๋จ (Propranolol, labetalol, esmolol)
โ€ข
Esmolol : Initial bolus 0.1~0.5mg/kg IV over 1min, infusion 0.025~0.2mg/kg/min
โ€ข
Labetalol : Initial 10~20mg IV, ์ดํ›„ repeat dose 20~40mg every 10 min(maximum 300mg)

(3) ฮฒ -blocker ๋ถ€์ ์‘์ฆ์ด๋‚˜ intolerenceํ™˜์ž

โ€ข
Non-dihydropyridine ๊ณ„ CCB (Vessel๋ณด๋‹ค๋Š” Heart์— ์ฃผ๋กœ ์ž‘์šฉํ•˜๋Š” CCB) ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ HR๋ฅผ ์กฐ์ ˆํ•œ๋‹ค (COR-2a, LOE-B)
โ€ข
Diltiazem (Herben), Verapamil (Isoptin) ์„ ์‚ฌ์šฉํ•œ๋‹ค.

(4) BP target (COR-1, LOE-C)

โ€ข
SBP > 120 mmHg ๋˜๋Š” ์ ์ ˆํ•œ end-organ perfusion์„ ์œ ์ง€ํ•  ์ˆ˜ ์žˆ๋Š” ์ตœ์†Œํ•œ์˜ ํ˜ˆ์•• ์œ ์ง€
โ€ข
๋งฅ๋ฐ•์ˆ˜๋Š” 60~80 bpm ์ •๋„๋ฅผ ๋ชฉํ‘œ๋กœ ์กฐ์ ˆ

E2. Vasodilator

(1) ฮฒ-blocker ๋ฅผ ์‚ฌ์šฉ์—๋„ ํ˜ˆ์•• ์กฐ์ ˆ ์•ˆ ๋˜๋ฉด ์ถ”๊ฐ€ (COR-1, LOE-C)
โ€ข
IV nicardipine (Perdipine), clevidipine, nitroglycerin, nitroprusside

E3. Pain killer

โ€ข
ํ†ต์ฆ์กฐ์ ˆ ์œ„ํ•ด pain killer ์‚ฌ์šฉํ•ด์•ผ ํ•จ. (COR-1, LOE-C)

โ…ฅ. Disposition and follow up

Malperfusion Tx. Options
AoD : indicates aortic dissection TEVAR : Thoracic Endovascular Aortic Repair
1.
Surgeon์—๊ฒŒ ๋น ๋ฅธ refer๊ฐ€ ๊ผญ ํ•„์š”ํ•˜๋ฉฐ emergency open repair๊ฐ€ ๋Œ€๋ถ€๋ถ„์˜ ํ™˜์ž์—์„œ TOC์ด๋‹ค. ํ•˜์ง€๋งŒ endovascular repair๋ฅผ ํ•˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋” ํ”ํ•˜๋‹ค
2.
์ค‘ํ™˜์ž์‹ค ์ž…์›, hemodynamic Tx. & careful monitoring ํ•„์š”
3.
Acute intermural hematoma, penetrating ulcer์˜ ๊ฒฝ์šฐ ์ž„์ƒ ์–‘์ƒ์˜ ๋ช…ํ™•ํ•˜์ง€ ์•Š์•„ ์ถ”ํ›„ ์ฒ˜์น˜๋ฅผ ๊ฒฐ์ •ํ•˜๋Š”๋ฐ ์ด๊ฒฌ์ด ์žˆ๋‹ค.
4.
๋ณธ์›์—์„œ๋Š” GS๋Š” infrarenal ๋งŒ. TS๋Š” Type A๋งŒ, ๊ทธ ์™ธ๋Š” CV๋กœ ์ž…์› (2024.09)

์ด๋Œ€์„œ์šธ๋ณ‘์›์‹ฌ์žฅํ˜ˆ๊ด€ ์ „์› ์‹œ ์นดํ†ก์œผ๋กœ ๋ณด๋‚ผ ๋‚ด์šฉ

1.
Symptom & onset time
2.
V/S BP / PR / SpO2 / Mental Neurologic examination
3.
Vasopressor infusion
4.
C-line, A-line ์—ฌ๋ถ€ ๋ฐ ์œ„์น˜
5.
NPO time
6.
ํ‚ค/๋ชธ๋ฌด๊ฒŒ/ํ˜ˆ์•กํ˜•
7.
๊ณผ๊ฑฐ๋ ฅ/์ˆ˜์ˆ ๋ ฅ
8.
ํ•ญํ˜ˆ์†ŒํŒ์ œ/ํ•ญ์‘๊ณ ์ œ ๋ณต์šฉ์—ฌ๋ถ€
9.
์ถœ๋ฐœ์˜ˆ์ •์‹œ๊ฐ„
10.
๋™ํ–‰์˜๋ฃŒ์ง„ ์—ฐ๋ฝ์ฒ˜

โ…ฆ. Special considerations

1.
Aortic dissection complicating pregnancy (1) Rareํ•˜๋ฉฐ ๋ณดํ†ต 3rd trimester postpartum period ์— ์ผ์–ด๋‚œ๋‹ค (2) Risk factors : Bicuspid aortic valve, connective tissue disorder, HTN, family hx (3) ์ง„๋‹จ ์‹œ ์‚ฐ๋ถ€์ธ๊ณผ, ํ‰๋ถ€์™ธ๊ณผ ํ˜‘์ง„์ด ํ•„์š”ํ•˜๋‹ค.